These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31765736)

  • 1. Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells.
    Yuan P; Yang T; Mu J; Zhao J; Yang Y; Yan Z; Hou Y; Chen C; Xing J; Zhang H; Li J
    Cancer Lett; 2020 Jan; 469():498-509. PubMed ID: 31765736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NPAS2 promotes cell survival of hepatocellular carcinoma by transactivating CDC25A.
    Yuan P; Li J; Zhou F; Huang Q; Zhang J; Guo X; Lyu Z; Zhang H; Xing J
    Cell Death Dis; 2017 Mar; 8(3):e2704. PubMed ID: 28333141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.
    Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X
    Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling.
    Ma S; Chen Y; Quan P; Zhang J; Han S; Wang G; Qi R; Zhang X; Wang F; Yuan J; Yang X; Jia W; Qin W
    BMC Cancer; 2023 Mar; 23(1):280. PubMed ID: 36978001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glypican-3 Enhances Reprogramming of Glucose Metabolism in Liver Cancer Cells.
    Yao G; Yin J; Wang Q; Dong R; Lu J
    Biomed Res Int; 2019; 2019():2560650. PubMed ID: 31781603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TFB2M activates aerobic glycolysis in hepatocellular carcinoma cells through the NAD
    Chang H; Li J; Luo Y; Wu B; Yuan C; Geng X
    J Gastroenterol Hepatol; 2021 Oct; 36(10):2978-2988. PubMed ID: 33982328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia disrupts the expression levels of circadian rhythm genes in hepatocellular carcinoma.
    Yu C; Yang SL; Fang X; Jiang JX; Sun CY; Huang T
    Mol Med Rep; 2015 May; 11(5):4002-8. PubMed ID: 25591621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small heterodimer partner/neuronal PAS domain protein 2 axis regulates the oscillation of liver lipid metabolism.
    Lee SM; Zhang Y; Tsuchiya H; Smalling R; Jetten AM; Wang L
    Hepatology; 2015 Feb; 61(2):497-505. PubMed ID: 25212631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
    Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
    J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
    Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
    J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth.
    Jia YY; Zhao JY; Li BL; Gao K; Song Y; Liu MY; Yang XJ; Xue Y; Wen AD; Shi L
    Oncotarget; 2016 Jun; 7(23):35257-69. PubMed ID: 27153552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis.
    Yi CH; Zheng T; Leaderer D; Hoffman A; Zhu Y
    Cancer Lett; 2009 Nov; 284(2):149-56. PubMed ID: 19457610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
    Hamaguchi T; Iizuka N; Tsunedomi R; Hamamoto Y; Miyamoto T; Iida M; Tokuhisa Y; Sakamoto K; Takashima M; Tamesa T; Oka M
    Int J Oncol; 2008 Oct; 33(4):725-31. PubMed ID: 18813785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NPAS2, transcriptionally activated by ARRB1, promotes the malignant behaviours of lung adenocarcinoma cells and regulates the reprogramming of glucose metabolism.
    Wang S; Huang C; Zheng Y; Wu X; Zhong Y
    Clin Exp Pharmacol Physiol; 2024 May; 51(5):e13860. PubMed ID: 38584327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
    Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear receptor-mediated cell-autonomous oscillatory expression of the circadian transcription factor, neuronal PAS domain protein 2 (NPAS2).
    Matsumura R; Matsubara C; Node K; Takumi T; Akashi M
    J Biol Chem; 2013 Dec; 288(51):36548-53. PubMed ID: 24196956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
    Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
    Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer.
    Yi C; Mu L; de la Longrais IA; Sochirca O; Arisio R; Yu H; Hoffman AE; Zhu Y; Katsaro D
    Breast Cancer Res Treat; 2010 Apr; 120(3):663-9. PubMed ID: 19649706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma.
    Zhou X; Chen J; Yi G; Deng M; Liu H; Liang M; Shi B; Fu X; Chen Y; Chen L; He Z; Wang J; Liu J
    Oncotarget; 2016 Jan; 7(1):873-84. PubMed ID: 26621849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.